# Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement

## TL;DR

This study explores barriers to accessing monoclonal antibody treatments for high-risk patients during the pandemic.

## Contribution

It highlights how social vulnerability affects treatment access despite prioritization of high-risk individuals.

## Key findings

- High-risk patients were prioritized for monoclonal antibody treatment.
- Patients with higher Social Vulnerability Index scores were less likely to attend infusions.
- Social factors may hinder equitable treatment access for vulnerable populations.

## Abstract

We conducted a retrospective exploratory study evaluating factors associated with selection to receive and infusion with coronavirus disease 2019 monoclonal antibodies. While priority was given to high-risk patients, patients with increased Social Vulnerability Index scores were less likely to present for infusion, raising concern that social factors created barriers to treatment.